Abstract
Background:
The aetiology of thyroid cancer is poorly understood, but it is possible that this malignancy has origins early in life. It is, however, currently unknown if birthweight, as an indicator of prenatal growth, is related to risks of thyroid cancer risk.
Objective:
To investigate if birthweight is associated with the later risk of thyroid cancer and its histological types.
Methods:
246,141 children (120,505 girls, 125,636 boys) from the Copenhagen School Health Records Register, born 1936–1989, were prospectively followed in the Danish Cancer Registry. Cox regressions were used to estimate hazards ratios (HR) and 95% confidence intervals (CI).
Results:
During follow up, 241 individuals (172 women, 69 men) were diagnosed with thyroid cancer (162 papillary, 53 follicular). Birthweight was significantly and positively associated with risk of thyroid cancer overall (HR=1.30 [95% CI: 1.03–1.64] per kilogram). There were no sex differences in the associations. Birthweight was positively and significantly associated with follicular thyroid cancer (HR=1.74 [95% CI: 1.07–2.82] per kilogram), but although there was indication of a positive association, it did not reach statistical significance for the more common papillary type (HR=1.20 [95% CI: 0.90–1.59] per kilogram).
Conclusion:
A heavier weight at birth is associated with an elevated risk of total and follicular thyroid cancer, which underscores that prenatal exposures may be important in thyroid cancer aetiology.
Keywords (MeSH): birthweight, cohort, histology, thyroid neoplasms
1. Introduction
Thyroid cancer is one of the less frequent cancers, nonetheless, it is the most common endocrine malignancy with more than 298,000 incident cases worldwide in 2012 [1]. During the last decades the incidence has steadily increased in numerous countries, including Denmark [2, 3]. These increases are partly attributable to diagnostic changes and improvements, but potentially also caused by trends in certain lifestyle and environmental factors [4–6].
The aetiology of thyroid cancer is currently not fully understood and only a few risk factors have been established. The only modifiable risk factors are exposure to ionizing radiation and adult overweight and non-modifiable risk factors include age, gender, race/ethnicity, and genetics [7–9]. Emerging evidence suggests that hormonal and reproductive factors are important for thyroid cancer development, as the disease is most common among women, with the highest female-to-male ratio for incidence occurring between menarche and menopause [7, 10].
Thyroid cancers are generally diagnosed at younger ages compared with most other adult cancer forms. As most previous studies focused on risk factors acting in mid- and late-adulthood, they may not have evaluated the most relevant time window for thyroid carcinogenesis [7]. Previously we found, in agreement with the evidence on adult body size [9, 11], that heavier children had an increased risk of thyroid cancer [12]. Evidence suggests that size at birth, as an indicator of prenatal growth, may also be related to the development of many forms of adult cancer [13–15]. Further, as the development of the thyroid gland begins very early in foetal life [16], it is plausible that size already at birth is relevant for thyroid cancer development. Nonetheless, the current evidence is scarce and inconclusive [17, 18].
To examine the potential early origins of thyroid cancer, we prospectively investigated the associations between birthweight and the risk of adult thyroid cancer, including its histological types, using a large Danish cohort.
2. Material and Methods
2.1. Cohort
The Copenhagen School Health Records Register (CSHRR) is a unique Danish database including computerized school health records on 372,636 children, born 1930 through 1989 [19]. Virtually all children in both public and private schools in the Copenhagen municipality underwent mandatory health examinations. For children born 1936 onwards their birthweight, as reported by their parent (either from recall or birth records) at the first school health examination, was recorded on their health card. The correlations between parental reported birthweight registered in the CSHRR and medical birth records have been found to be high (above 0.93) [20], emphasising the validity of this information. Childhood weights and heights were measured by trained school physicians or nurses with high precision [19].
2.2. Linkages
Follow-up of children in the CSHRR was based on record linkages to national health registers using the unique government-issued identification number assigned to all Danish residents alive in 1968 or born thereafter [21]. These identification numbers were recorded on the health cards for children attending school in 1968 or later and retrieved for those leaving school prior to this time. Approximately 89% of the children in the cohort had an available identification number. Information on vital status was obtained from the Danish Civil Registration System [21].
Through linkages to the Danish Cancer Registry, which has almost complete coverage due to compulsory registration, and a very high validity as most tumours are morphologically verified, incident thyroid cancers were identified [22]. Due to a recoding project of the Danish Cancer Registry, International Classification of Disease (ICD) version 10 codes and ICD for Oncology version 3 (ICD-O-3) morphology codes were available for thyroid cancers diagnosed from 1968 onwards. In the current study, thyroid cancers diagnosed from 1968–2015 were included. Thyroid cancer was defined as malignant carcinoma of the thyroid gland and classified using the C73.9 disease code. Using ICD-O-3 morphology codes, thyroid cancers were sub-classified into the histological types of papillary (8050, 8260, 8340), follicular (8290, 8330, 8331), and other (8010, 8020, 8021, 8070, 8345, 8510) thyroid cancers. Individuals without morphology information were reclassified as non-cases and censored at the time of diagnosis (n=6).
2.3. Study population
Individuals eligible for this study were born 1936–1989, had an available identification number and were alive and living in Denmark at the age of 15 years or older (Supplementary Figure 1). Among these 290,946 individuals, we excluded individuals with a diagnosis of thyroid cancer before age 15 years (n=2) or prior to 1968 (n=1), with missing birthweight information (n=39,960) and with birthweights outside of the reliable range of 2.0–5.5 kg (n=4,842) leaving a total of 246,141 individuals (120,505 women and 125,636 men) for analyses. From this group, 233,807 individuals (114,461 women and 119,346 men) had information available on body size at age 7 years.
Follow-up began at the age of 15 years or the age in 1968, whichever came later, and ended at the age of a diagnosis of thyroid cancer, emigration, death, loss to follow-up, or 31 December 2015, whichever occurred first.
2.4. Statistical analyses
Characteristics of the cohort are presented as means and standard deviations of birthweight across time and by sex. The associations between birthweight and risk of thyroid cancer, including its histological types, were investigated using Cox proportional hazard models and presented as hazard ratios (HRs) with 95% confidence intervals (CIs). Age was used as the underlying time scale and analyses were stratified by birth cohort and sex (when applicable). The linearity of the associations was assessed using linear splines with 2 knots positioned at 3.25 and 3.75kg using the likelihood ratio test. We did not detect non-linearity in any of the associations (all p-values ≥ 0.23), thus, associations are presented per kilogram of birthweight. Associations are also presented by birthweight categories (2.0–3.25, 3.26–3.75, 3.76–5.5kg) for comparison with other studies examining birthweight associations. The assumption of proportional hazards in the associations were investigated by testing if these differed by categories of age at diagnosis using the likelihood ratio test. Potential interactions by sex and birth cohort, respectively, on the associations between birthweight and risk of thyroid cancer were similarly investigated using the likelihood ratio test. As birthweight and childhood body mass index (BMI) are correlated [23], in a subset of individuals with information on both birthweight and BMI at age 7 years, we examined the effect of adjusting the birthweight and thyroid cancer associations for childhood BMI. These analyses showed that the birthweight and thyroid cancer associations were essentially unchanged (results not shown).
3. Results
Among the 246,141 individuals (120,505 women and 125,636 men) included in the study, the mean birthweight varied little across time in men and women (Table 1). During 47 years and 9,1 million person-years of follow up, 241 individuals (172 women and 69 men) were diagnosed with thyroid cancer, of which 162 were papillary (117 women and 45 men), 53 follicular (40 women and 13 men) and the remaining 26 were other histological thyroid types. The median age at diagnosis with thyroid cancer overall was 48 years (range: 16–78 years) for both sexes combined, and 48 years (range: 16–78 years) for women and 48 years (range: 22–76 years) for men. For the papillary type, the median age at diagnosis was slightly lower, namely 46 years (range: 16–78 years), and slightly higher for the follicular type at 49 years (range: 27–69 years), for women and men combined.
Table 1.
Birthweight characteristics by birth cohort and sex of individuals in the Copenhagen School Health Records Register born 1936–1989
| Women and men | Women | Men | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | Birthweight (kg) | n | Birthweight (kg) | n | Birthweight (kg) | ||||
| Year of birth | Mean | SD | Mean | SD | Mean | SD | |||
| Overall | 246,141 | 3.37 | 0.54 | 120,505 | 3.31 | 0.52 | 125,636 | 3.43 | 0.55 |
| 1936–1939 | 21,200 | 3.43 | 0.57 | 10,081 | 3.37 | 0.56 | 11,119 | 3.48 | 0.57 |
| 1940–1944 | 39,649 | 3.40 | 0.55 | 19,466 | 3.33 | 0.53 | 20,183 | 3.46 | 0.56 |
| 1945–1949 | 41,504 | 3.39 | 0.55 | 20,467 | 3.32 | 0.53 | 21,037 | 3.45 | 0.56 |
| 1950–1954 | 30,012 | 3.35 | 0.55 | 14,815 | 3.29 | 0.53 | 15,197 | 3.41 | 0.55 |
| 1955–1959 | 24,330 | 3.33 | 0.54 | 11,891 | 3.27 | 0.52 | 12,439 | 3.39 | 0.55 |
| 1960–1964 | 19,610 | 3.35 | 0.53 | 9,655 | 3.28 | 0.51 | 9,955 | 3.41 | 0.55 |
| 1965–1969 | 17,720 | 3.36 | 0.52 | 8,763 | 3.29 | 0.51 | 8,957 | 3.42 | 0.53 |
| 1970–1974 | 14,770 | 3.36 | 0.52 | 7,245 | 3.29 | 0.50 | 7,525 | 3.42 | 0.53 |
| 1975–1979 | 12,459 | 3.36 | 0.52 | 6,069 | 3.30 | 0.49 | 6,390 | 3.41 | 0.53 |
| 1980–1984 | 11,142 | 3.35 | 0.52 | 5,304 | 3.28 | 0.49 | 5,838 | 3.41 | 0.53 |
| 1985–1989 | 13,745 | 3.40 | 0.52 | 6,749 | 3.34 | 0.50 | 6,996 | 3.46 | 0.53 |
SD=standard deviation; kg=kilogram
Birthweight was significantly and positively associated with risk of thyroid cancer overall, with a HR of 1.30 (95% CI: 1.03–1.64) per kilogram increase (Figure 1, Supplementary Table 1). We similarly observed that birthweight was significantly and positively associated with the risk of follicular thyroid cancer, with a higher HR of 1.74 (95% CI: 1.07–2.82) per kilogram (Figure 1, Supplementary Table 1). Nonetheless, the confidence intervals for the associations with overall thyroid cancer and the follicular type were overlapping. In contrast, although we found similar indications that birthweight and papillary thyroid cancer was positively associated, the association did not reach statistical significance (HR=1.20 [95% CI: 0.90–1.59] per kilogram) (Figure 1, Supplementary Table 1). We did not identify violations of the proportional hazards assumption (all p-values ≥ 0.20), sex interactions (all p-values ≥ 0.65) or birth cohort effects (all p-values ≥ 0.11) in any of the associations.
Figure 1.

Associations between birthweight (per kilogram) and thyroid cancer overall and by histological type for women and men combined and by sexa
CI=confidence interval
a Cox proportional hazards regression models stratified by birth cohort. Analyses for both sexes combined are additionally stratified by sex.
Although there were suggestions of positive associations between birthweight and thyroid cancer overall and its histological types for both women and men individually, none of these reached statistical significance (Figure 1, Supplementary Table 1). When birthweight was modelled categorically, in comparison with children with an average size at birth, children in the highest birthweight category had an increased risk of follicular thyroid cancer and a borderline significantly increased risk of thyroid cancer overall in analyses combining women and men, whereas no significant associations were found for papillary thyroid cancer as well as in analyses for women and men separately (Table 2).
Table 2.
Associations between three categories of birthweight and thyroid cancer overall and by histological type for women and men combined and by sexa
| Women and menb | Women | Men | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Type | Categories | N | Cases | HR | 95 % CI | pc | N | Cases | HR | 95 % CI | pc | n | Cases | HR | 95 % CI | pc |
| All | 1 (2–3.25kg) | 106,069 | 97 | 0.92 | 0.68–1.23 | 58,021 | 75 | 0.96 | 0.68–1.35 | 48,145 | 22 | 0.82 | 0.47–1.45 | |||
| 2 (3.26–3.75kg) | 88,676 | 83 | 1.00 (ref.) | 42,293 | 57 | 1.00 (ref.) | 46,383 | 26 | 1.00 (ref.) | |||||||
| 3 (3.76–5.5kg) | 51,299 | 61 | 1.38 | 0.99–1.92 | 20,191 | 40 | 1.47 | 0.98–2.21 | 31,108 | 21 | 1.20 | 0.68–2.14 | ||||
| 0.87 | 0.81 | 0.23 | ||||||||||||||
| Papillary | 1 (2–3.25kg) | 106,166 | 97 | 0.90 | 0.63–1.27 | 58,021 | 75 | 1.02 | 0.68–1.54 | 48,145 | 22 | 0.63 | 0.31–1.26 | |||
| 2 (3.26–3.75kg) | 88,676 | 83 | 1.00 (ref.) | 42,293 | 57 | 1.00 (ref.) | 46,383 | 26 | 1.00 (ref.) | |||||||
| 3 (3.76–5.5kg) | 51,299 | 61 | 1.12 | 0.74–1.71 | 20,191 | 40 | 1.25 | 0.74–2.09 | 31,108 | 21 | 0.90 | 0.44–1.85 | ||||
| 0.95 | 0.71 | 0.72 | ||||||||||||||
| Follicular | 1 (2–3.25kg) | 106,166 | 97 | 1.04 | 0.53–2.04 | 58,021 | 75 | 0.98 | 0.46–2.07 | 48,145 | 22 | 1.31 | 0.29–5.86 | |||
| 2 (3.26–3.75kg) | 88,676 | 83 | 1.00 (ref.) | 42,293 | 57 | 1.00 (ref.) | 46,383 | 26 | 1.00 (ref.) | |||||||
| 3 (3.76–5.5kg) | 51,299 | 61 | 2.26 | 1.14–4.48 | 20,191 | 40 | 2.07 | 0.93–4.61 | 31,108 | 21 | 2.91 | 0.73–11.65 | ||||
| 0.88 | 0.90 | 0.51 | ||||||||||||||
CI=confidence interval; HR=hazard ratio; kg=kilogram
Cox proportional hazards regression models stratified by birth cohort
Additionally stratified by sex
Test for linearity using the likelihood ratio test for linear splines with 2 knots positioned at 3.25 and 3.75 kilograms
4. Discussion
In this large cohort study, birthweight was positively associated with risk of thyroid cancer overall. When histological types were examined, we found that birthweight was positively associated with follicular thyroid cancer, despite a very low case number. In contrast we did not detect significant associations between birthweight and the most common histological type of papillary thyroid cancers.
Accumulating evidence during the last decades supports that early life factors, including size at birth as an indicator of foetal growth, are linked to the incidence and mortality of several cancers in adult life [13–15]. Owing to the rarity of thyroid neoplasms, often precluding investigations of histological types, and partly due to the scarcity of large cohort studies with prospective evaluations of exposures, much remains unknown about the associations between birthweight and thyroid cancer. In a study by Johnson et al. [17] the authors investigated associations between birthweight and childhood carcinomas (≤14 years), including 159 thyroid cancers, and did not find that a high birthweight increased the risk of thyroid cancer (odds ratio [OR]=1.02 [95% CI: 0.87–1.20] per 0.5 kilogram). The aetiology of childhood thyroid carcinomas is likely different from thyroid cancers occurring later in life making these findings less comparable with those of the present study, where the mean age at diagnosis was 49 years. A study by Crump et al. [18] found that size at birth of the offspring was positively related to risk of maternal thyroid cancer, however, these findings are not directly comparable with our study.
In another study using the CSHRR we previously found that a greater BMI during childhood ages was significantly and positively associated with risk of thyroid cancer overall and papillary but not follicular thyroid cancer [12]. Since a high birthweight is positively associated with childhood overweight among both boys and girls [23], we had hypothesized that birthweight and papillary thyroid cancer in particular would be positively associated. Somewhat surprisingly, we found that although there were indications that birthweight was positively associated with risk of papillary thyroid cancer, the association only reached statistical significance for the less common follicular thyroid cancer
A potential underlying mechanism that could explain the association observed between birthweight and risk of follicular thyroid cancer in our cohort study is fetal iodine deficiency. Iodine deficiency can lead to an increased risk of thyroid dysfunction in the mothers and offspring, which may, among other things, affect fetal growth [24]. In 1998, a national voluntary salt iodization program was introduced as the population of eastern Denmark, including Copenhagen, had been mildly iodine deficient while western Denmark was moderately iodine deficient. Following a mandatory fortification program initiated in 2000, the population iodine intake was found to be adequate in most groups [25]. Even in iodine sufficient populations, however, pregnant women remain vulnerable to iodine deficiency due to the high iodine requirements of the fetus. Iodine status has long been hypothesized to play a role in thyroid carcinogenesis, based on ecological studies showing higher follicular thyroid cancer incidence in areas of iodine deficiency and a higher ratio of papillary to follicular thyroid cancer incidence following regional iodine fortification programs [26–28]. Thus, it is plausible that iodine status is important in the link between birthweight and thyroid cancer risk, however, this and other mechanisms remain speculative and need to be elucidated further.
Among the major strengths of the present study are the available information on birthweight on a large unselected population of Copenhagen school children born before, during and after World War II. Another strength is that information on birthweight was available from parental recall of birthweight or birth records, with a short period of time of recall, which has a very high accuracy [20, 29–31], as compared with studies asking individuals to recall their own birthweight several decades later. Additionally, record linkages via unique identification numbers to the high-quality national Danish Cancer Registry enabled almost complete follow-up for thyroid cancer incidence, starting from young ages, and included medically-verified histological types. This study might, however, be limited by a lack of information on gestational age and birth length as well as pregnancy characteristics potentially related to foetal growth, such as maternal smoking, weight gain, vitamin supplementation and maternal iodine status during pregnancy. Nonetheless, as these behaviours and factors likely varied across the 54 years of birth included in our study and as we did not detect birth cohort effects, they are unlike to explain the entirety of the associations we observed. Even though birthweight information was available for a large population, the number of individuals registered with a diagnosis of thyroid cancer during follow-up was, unsurprisingly, relatively low, as thyroid cancer is a fairly uncommon cancer. Nonetheless, our study was sufficiently powered to investigate the associations under question. As individuals included in this study were largely Caucasians, our study findings are likely generalizable to many other populations of Western origin.
In conclusion, we found that weight at birth was positively and significantly associated with the risk of thyroid cancer overall and the histological type of follicular thyroid cancer, but only indications of a positive association with the most common histological type of papillary thyroid cancer. Although replication in other populations is needed and the direct clinical implications are limited, these findings aid in our understanding of thyroid carcinogenesis and point to a role of in utero exposures or shared genetic determinants of early life body size on thyroid cancer risk.
Supplementary Material
Funding Sources
This work was supported by the European Research Council under the European Union’s Seventh Framework Programme [(FP/2007-2013)/ERC, 281419 to JLB], the Danish Council for Independent Research [(DFF)|FSS 1331-00218 to JLB], and Dr. Sofus Carl Emil Friis and wife Olga Doris’ Fund to JLB. The intramural research program of the US National Cancer Institute funded CMK. The funding sources had no involvement in the study design, collection, analysis and interpretation of data, writing the article and decision to submit.
Footnotes
Statement of Ethics
This study was approved by the Danish Data Protection Agency. According to Danish law, ethical approval is not required for register-based studies.
Declaration of Interest: none.
References
- [1].Globocan. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. International Agency on Cancer (IARC). World Health Organization (WHO), http://globocan.iarc.fr/, [accessed September 2018]. [Google Scholar]
- [2].Blomberg M, Feldt-Rasmussen U, Andersen KK, Kjaer SK, Thyroid cancer in Denmark 1943–2008, before and after iodine supplementation, Int J Cancer 131(10) (2012) 2360–6. doi: 10.1002/ijc.27497. [DOI] [PubMed] [Google Scholar]
- [3].James BC, Mitchell JM, Jeon HD, Vasilottos N, Grogan RH, Aschebrook-Kilfoy B, An update in international trends in incidence rates of thyroid cancer, 1973–2007, Cancer Causes Control 29(4–5) (2018) 465–473. doi: 10.1007/s10552-018-1023-2. [DOI] [PubMed] [Google Scholar]
- [4].Morris LG, Sikora AG, Tosteson TD, Davies L, The increasing incidence of thyroid cancer: the influence of access to care, Thyroid 23(7) (2013) 885–91. doi: 10.1089/thy.2013.0045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Kitahara CM, Sosa JA, The changing incidence of thyroid cancer, Nat Rev Endocrinol 12(11) (2016) 646–653. doi: 10.1038/nrendo.2016.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM, Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974–2013, JAMA 317(13) (2017) 1338–1348. doi: 10.1001/jama.2017.2719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Kitahara CM, Schneider AB, Brenner AV, Thyroid Cancer, in: Thun M, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D (Eds.), Cancer Epidemiology and Prevention, Oxford University Press; 2017, pp. 839–861. [Google Scholar]
- [8].Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, et al. , Body Fatness and Cancer--Viewpoint of the IARC Working Group, N Engl J Med 375(8) (2016) 794–8. doi: 10.1056/NEJMsr1606602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Kitahara CM, McCullough ML, Franceschi S, Rinaldi S, Wolk A, Neta G, et al. , Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies, Thyroid 26(2) (2016) 306–18. doi: 10.1089/thy.2015.0319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Troisi R, Bjorge T, Gissler M, Grotmol T, Kitahara CM, Myrtveit Saether SM, et al. , The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence, J Intern Med 283(5) (2018) 430–445. doi: 10.1111/joim.12747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Dal Maso L, La Vecchia C, Franceschi S, Preston-Martin S, Ron E, Levi F, et al. , A pooled analysis of thyroid cancer studies. V. Anthropometric factors, Cancer Causes Control 11(2) (2000) 137–44. doi: [DOI] [PubMed] [Google Scholar]
- [12].Kitahara CM, Gamborg M, Berrington de Gonzalez A, Sørensen TIA, Baker JL, Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study, Cancer Res. 74(1) (2014) 235–242. doi: 0008–5472.CAN-13–2228 [pii]; 10.1158/0008-5472.CAN-13-2228 [doi]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Height and birthweight and the risk of cancer. Available at dietandcancerreport.org. [Google Scholar]
- [14].McCormack VA, dos Santos Silva I, Koupil I, Leon DA, Lithell HO, Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women, Int J Cancer 115(4) (2005) 611–617. doi: 10.1002/ijc.20915 [doi]. [DOI] [PubMed] [Google Scholar]
- [15].Risnes KR, Vatten LJ, Baker JL, Jameson K, Sovio U, Kajantie E, et al. , Birthweight and mortality in adulthood: a systematic review and meta-analysis, Int. J. Epidemiol 40(3) (2011) 647–61. doi: 10.1093/ije/dyq267. [DOI] [PubMed] [Google Scholar]
- [16].Kratzsch J, Pulzer F, Thyroid gland development and defects, Best Pract Res Clin Endocrinol Metab 22(1) (2008) 57–75. doi: 10.1016/j.beem.2007.08.006. [DOI] [PubMed] [Google Scholar]
- [17].Johnson KJ, Carozza SE, Chow EJ, Fox EE, Horel S, McLaughlin CC, et al. , Birth characteristics and childhood carcinomas, Br J Cancer 105(9) (2011) 1396–401. doi: 10.1038/bjc.2011.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Crump C, Sundquist J, Sieh W, Winkleby MA, Sundquist K, Fetal growth and subsequent maternal risk of thyroid cancer, Int J Cancer 138(5) (2016) 1085–93. doi: 10.1002/ijc.29857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Baker JL, Olsen LW, Andersen I, Pearson S, Hansen B, Sørensen TIA, Cohort profile: the Copenhagen School Health Records Register, Int. J. Epidemiol 38(3) (2009) 656–662. doi: dyn164 [pii]; 10.1093/ije/dyn164 [doi]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Jensen CB, Gamborg M, Heitmann B, Sørensen TIA, Baker JL, Comparison of birth weight between school health records and medical birth records in Denmark: determinants of discrepancies, BMJ Open 5(11) (2015) e008628. doi: 10.1136/bmjopen-2015-008628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [21].Pedersen CB, The Danish Civil Registration System, Scand.J.Public Health 39(7 Suppl) (2011) 22–25. doi: 39/7_suppl/22 [pii]; 10.1177/1403494810387965 [doi]. [DOI] [PubMed] [Google Scholar]
- [22].Gjerstorff ML, The Danish Cancer Registry, Scand J Public Health 39(7 Suppl) (2011) 42–45. doi: 39/7_suppl/42 [pii]; 10.1177/1403494810393562 [doi]. [DOI] [PubMed] [Google Scholar]
- [23].Rugholm S, Baker JL, Olsen LW, Schack-Nielsen L, Bua J, Sørensen TIA, Stability of the association between birth weight and childhood overweight during the development of the obesity epidemic, Obes Res 13(12) (2005) 2187–94. doi: 10.1038/oby.2005.271. [DOI] [PubMed] [Google Scholar]
- [24].Pearce EN, Lazarus JH, Moreno-Reyes R, Zimmermann MB, Consequences of iodine deficiency and excess in pregnant women: an overview of current knowns and unknowns, Am J Clin Nutr 104 Suppl 3 (2016) 918S–23S. doi: 10.3945/ajcn.115.110429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [25].Rasmussen LB, Carle A, Jorgensen T, Knudsen N, Laurberg P, Pedersen IB, et al. , Iodine intake before and after mandatory iodization in Denmark: results from the Danish Investigation of Iodine Intake and Thyroid Diseases (DanThyr) study, Br J Nutr 100(1) (2008) 166–73. doi: 10.1017/S0007114507886387. [DOI] [PubMed] [Google Scholar]
- [26].Pettersson B, Adami HO, Wilander E, Coleman MP, Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type, Int J Cancer 48(1) (1991) 28–33. doi: [DOI] [PubMed] [Google Scholar]
- [27].Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W, Moncayo R, Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country, Thyroid 7(5) (1997) 733–41. doi: 10.1089/thy.1997.7.733. [DOI] [PubMed] [Google Scholar]
- [28].Burgess JR, Dwyer T, McArdle K, Tucker P, Shugg D, The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978–1998) during a transition from iodine sufficiency to iodine deficiency, J Clin Endocrinol Metab 85(4) (2000) 1513–7. doi: 10.1210/jcem.85.4.6554. [DOI] [PubMed] [Google Scholar]
- [29].Rice F, Lewis A, Harold G, van den Bree M, Boivin J, Hay DF, et al. , Agreement between maternal report and antenatal records for a range of pre and peri-natal factors: the influence of maternal and child characteristics, Early Hum Dev 83(8) (2007) 497–504. doi: 10.1016/j.earlhumdev.2006.09.015. [DOI] [PubMed] [Google Scholar]
- [30].Walton KA, Murray LJ, Gallagher AM, Cran GW, Savage MJ, Boreham C, Parental recall of birthweight: a good proxy for recorded birthweight?, Eur.J.Epidemiol 16(9) (2000) 793–796. doi: [DOI] [PubMed] [Google Scholar]
- [31].O’Sullivan JJ, Pearce MS, Parker L, Parental recall of birth weight: how accurate is it?, Arch Dis Child 82(3) (2000) 202–3. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
